Qube Research & Technologies (QRT)
BIOR

Qube Research & Technologies (QRT)’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$135 – 5028
2023
Q4 		$135 Buy
+10
New +$162 ﹤0.01% 4005

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIOR Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 10 shares — an estimated $135 sold.

Qube Research & Technologies (QRT) first reported a position in BIOR in Q4 2023 and held it in 1 quarter. The position peaked at $135 in Q4 2023. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $135.
  • Qube Research & Technologies (QRT) first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Biora Therapeutics, Inc. Common Stock position peaked at $135 in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.